Coinciding with a new start upon the complete integration of the DAIICHI SANKYO Group, we have amended our Corporate Conduct Charter.

The DAIICHI SANKYO Group aims to contribute to a healthy and prosperous life for people worldwide through the continual development and provision of innovative pharmaceuticals.

In every aspect of our business activities, the group will comply with laws and regulations and promote compliance-based management with high ethical standards. We will promote our corporate values (social, economic, and humanistic values) in a well-balanced proportions to meet the expectations of our stakeholders.

With a spirit of challenge and creative ingenuity, all employees, including board members, corporate auditors, and corporate officers, will act within the highest standards of professionalism and work together toward actively fulfilling our corporate social responsibilities.

April 1, 2007
Takashi Shoda
President and Representative Director